Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in Saccharomyces cerevisiae.

McDonald MG, Ray S, Amorosi CJ, Sitko KA, Kowalski JP, Paco L, Nath A, Gallis B, Totah RA, Dunham MJ, Fowler DM, Rettie AE.

Drug Metab Dispos. 2017 Dec;45(12):1364-1371. doi: 10.1124/dmd.117.078188. Epub 2017 Oct 10.

2.

Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Swiderski K, Shaffer SA, Gallis B, Odom GL, Arnett AL, Scott Edgar J, Baum DM, Chee A, Naim T, Gregorevic P, Murphy KT, Moody J, Goodlett DR, Lynch GS, Chamberlain JS.

Hum Mol Genet. 2014 Dec 20;23(25):6697-711. doi: 10.1093/hmg/ddu388. Epub 2014 Jul 31.

3.

pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.

Zhang YJ, Gallis B, Taya M, Wang S, Ho RJ, Sasaki T.

PLoS One. 2013;8(3):e59086. doi: 10.1371/journal.pone.0059086. Epub 2013 Mar 14.

4.

Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.

Gong Y, Gallis BM, Goodlett DR, Yang Y, Lu H, Lacoste E, Lai H, Sasaki T.

Anticancer Res. 2013 Jan;33(1):123-32.

PMID:
23267137
5.

Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.

Morrissey C, Gallis B, Solazzi JW, Kim BJ, Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL, Sasaki T.

Anticancer Drugs. 2010 Apr;21(4):423-32. doi: 10.1097/CAD.0b013e328336f57b.

6.

Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein.

Parra MC, Shaffer SA, Hajjar AM, Gallis BM, Hager A, Goodlett DR, Guina T, Miller S, Collins CM.

Microbiol Res. 2010 Sep 20;165(7):531-45. doi: 10.1016/j.micres.2009.11.004. Epub 2009 Dec 14.

7.

Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.

Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, Goodlett DR, Tanaka S, Futaki S, Lai H, Sasaki T.

Cancer Lett. 2009 Feb 18;274(2):290-8. doi: 10.1016/j.canlet.2008.09.023. Epub 2008 Nov 8.

PMID:
19006645
8.

Determination and comparison of the Francisella tularensis subsp.novicida U112 proteome to other bacterial proteomes.

Rohmer L, Guina T, Chen J, Gallis B, Taylor GK, Shaffer SA, Miller SI, Brittnacher MJ, Goodlett DR.

J Proteome Res. 2008 May;7(5):2016-24. doi: 10.1021/pr700760z. Epub 2008 Apr 2.

PMID:
18380474
9.

Comparison of a label-free quantitative proteomic method based on peptide ion current area to the isotope coded affinity tag method.

Ryu S, Gallis B, Goo YA, Shaffer SA, Radulovic D, Goodlett DR.

Cancer Inform. 2008;6:243-55. Epub 2008 Apr 17.

10.

MglA regulates Francisella tularensis subsp. novicida (Francisella novicida) response to starvation and oxidative stress.

Guina T, Radulovic D, Bahrami AJ, Bolton DL, Rohmer L, Jones-Isaac KA, Chen J, Gallagher LA, Gallis B, Ryu S, Taylor GK, Brittnacher MJ, Manoil C, Goodlett DR.

J Bacteriol. 2007 Sep;189(18):6580-6. Epub 2007 Jul 20.

11.

Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains.

Rohmer L, Fong C, Abmayr S, Wasnick M, Larson Freeman TJ, Radey M, Guina T, Svensson K, Hayden HS, Jacobs M, Gallagher LA, Manoil C, Ernst RK, Drees B, Buckley D, Haugen E, Bovee D, Zhou Y, Chang J, Levy R, Lim R, Gillett W, Guenthener D, Kang A, Shaffer SA, Taylor G, Chen J, Gallis B, D'Argenio DA, Forsman M, Olson MV, Goodlett DR, Kaul R, Miller SI, Brittnacher MJ.

Genome Biol. 2007;8(6):R102.

12.

Identification and type III-dependent secretion of the Yersinia pestis insecticidal-like proteins.

Gendlina I, Held KG, Bartra SS, Gallis BM, Doneanu CE, Goodlett DR, Plano GV, Collins CM.

Mol Microbiol. 2007 Jun;64(5):1214-27.

13.

Characterization of hepatic glutathione S-transferases in coho salmon (Oncorhynchus kisutch).

Trute M, Gallis B, Doneanu C, Shaffer S, Goodlett D, Gallagher E.

Aquat Toxicol. 2007 Feb 28;81(2):126-36. Epub 2006 Nov 24.

14.

Comparison of a Salmonella typhimurium proteome defined by shotgun proteomics directly on an LTQ-FT and by proteome pre-fractionation on an LCQ-DUO.

Nunn BL, Shaffer SA, Scherl A, Gallis B, Wu M, Miller SI, Goodlett DR.

Brief Funct Genomic Proteomic. 2006 Jun;5(2):154-68. Review.

PMID:
16798750
15.

Fluid shear stress-induced nitric oxide production in human cavernosal endothelial cells: inhibition by hyperglycaemia.

Wessells H, Teal TH, Engel K, Sullivan CJ, Gallis B, Tran KB, Chitaley K.

BJU Int. 2006 May;97(5):1047-52.

16.

Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells.

Kim F, Tysseling KA, Rice J, Gallis B, Haji L, Giachelli CM, Raines EW, Corson MA, Schwartz MW.

J Mol Cell Cardiol. 2005 Aug;39(2):327-34.

PMID:
15978611
17.

Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta.

Kim F, Tysseling KA, Rice J, Pham M, Haji L, Gallis BM, Baas AS, Paramsothy P, Giachelli CM, Corson MA, Raines EW.

Arterioscler Thromb Vasc Biol. 2005 May;25(5):989-94. Epub 2005 Feb 24.

PMID:
15731493
18.

Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin.

Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG.

J Histochem Cytochem. 2003 Mar;51(3):275-83.

PMID:
12588955
19.

TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells.

Kim F, Gallis B, Corson MA.

Am J Physiol Cell Physiol. 2001 May;280(5):C1057-65.

20.

A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.

Miyakawa Y, Drachman JG, Gallis B, Kaushansky A, Kaushansky K.

J Biol Chem. 2000 Oct 13;275(41):32214-9.

21.

Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002.

Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, Corson MA.

J Biol Chem. 1999 Oct 15;274(42):30101-8.

23.

p90(RSK) is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory phosphorylation of serine 703 of Na+/H+ exchanger isoform-1.

Takahashi E, Abe J, Gallis B, Aebersold R, Spring DJ, Krebs EG, Berk BC.

J Biol Chem. 1999 Jul 16;274(29):20206-14.

24.

Metal-binding properties of a calcium-dependent monoclonal antibody.

Hopp TP, Gallis B, Prickett KS.

Mol Immunol. 1996 May-Jun;33(7-8):601-8.

PMID:
8760271
25.

Interleukin 2 stimulates serine phosphorylation of CD45 in CTLL-2.4 cells.

Valentine MA, Widmer MB, Ledbetter JA, Pinault F, Voice R, Clark EA, Gallis B, Brautigan DL.

Eur J Immunol. 1991 Apr;21(4):913-9.

PMID:
1850360
26.

Monoclonal antibodies block murine IL-4 receptor function.

Beckmann MP, Schooley KA, Gallis B, Vanden Bos T, Friend D, Alpert AR, Raunio R, Prickett KS, Baker PE, Park LS.

J Immunol. 1990 Jun 1;144(11):4212-7.

PMID:
1692858
27.

Membrane bound forms of human macrophage colony stimulating factor (M-CSF, CSF-1).

Cerretti DP, Wignall J, Anderson D, Tushinski RJ, Gallis B, Cosman D.

Prog Clin Biol Res. 1990;352:63-70. No abstract available.

PMID:
2205876
28.

The molecular biology of large animal cytokines.

Maliszewski C, Gallis B, Baker PE.

Adv Vet Sci Comp Med. 1990;35:181-213. Review. No abstract available.

PMID:
2126669
29.

IL-1 induces rapid phosphorylation of the IL-1 receptor.

Gallis B, Prickett KS, Jackson J, Slack J, Schooley K, Sims JE, Dower SK.

J Immunol. 1989 Nov 15;143(10):3235-40.

PMID:
2530274
30.

T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.

Curtis BM, Gallis B, Overell RW, McMahan CJ, DeRoos P, Ireland R, Eisenman J, Dower SK, Sims JE.

Proc Natl Acad Sci U S A. 1989 May;86(9):3045-9.

31.

Antimicrobial activity of synthetic bactenecin.

Gallis B, Mehl J, Prickett KS, Martin JA, Merriam J, March CJ, Cerretti DP.

Biotechnol Ther. 1989-1990;1(4):335-46.

PMID:
2562655
32.

Human macrophage colony stimulating factor (M-CSF): alternate RNA splicing generates three different proteins that are expressed on the cell surface and secreted.

Cosman D, Wignall J, Anderson D, Tushinski J, Gallis B, Urdal D, Cerretti DP.

Behring Inst Mitt. 1988 Aug;(83):15-26.

PMID:
3071332
33.

Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene.

Cerretti DP, Wignall J, Anderson D, Tushinski RJ, Gallis BM, Stya M, Gillis S, Urdal DL, Cosman D.

Mol Immunol. 1988 Aug;25(8):761-70.

PMID:
2460758
34.

Monoclonal antibody immunoprecipitation of cell membrane glycoproteins.

Peltz GA, Gallis B, Peterlin BM.

Anal Biochem. 1987 Dec;167(2):239-44.

PMID:
3442319
35.

Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src.

Overell RW, Watson JD, Gallis B, Weisser KE, Cosman D, Widmer MB.

Mol Cell Biol. 1987 Oct;7(10):3394-401.

36.
37.
38.

Characterization of the phosphotyrosyl protein phosphatase activity of calmodulin-dependent protein phosphatase.

Chan CP, Gallis B, Blumenthal DK, Pallen CJ, Wang JH, Krebs EG.

J Biol Chem. 1986 Jul 25;261(21):9890-5.

39.

Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.

Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, Beavo JA.

Mol Pharmacol. 1986 May;29(5):506-14.

PMID:
3010079
40.

Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain.

Gallis B, Lewis A, Wignall J, Alpert A, Mochizuki DY, Cosman D, Hopp T, Urdal D.

J Biol Chem. 1986 Apr 15;261(11):5075-80.

41.

Epidermal growth factor stimulates tyrosine phosphorylation of the myosin regulatory light chain from smooth muscle.

Gallis B, Edelman AM, Casnellie JE, Krebs EG.

J Biol Chem. 1983 Nov 10;258(21):13089-93.

42.

Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner.

Pike LJ, Marquardt H, Todaro GJ, Gallis B, Casnellie JE, Bornstein P, Krebs EG.

J Biol Chem. 1982 Dec 25;257(24):14628-31.

43.

Partial purification and characterization of phosphotyrosyl-protein phosphatase from Ehrlich ascites tumor cells.

Hörlein D, Gallis B, Brautigan DL, Bornstein P.

Biochemistry. 1982 Oct 26;21(22):5577-84.

PMID:
6293548
44.

Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes.

Pike LJ, Gallis B, Casnellie JE, Bornstein P, Krebs EG.

Proc Natl Acad Sci U S A. 1982 Mar;79(5):1443-7.

45.
46.

Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn.

Brautigan DL, Bornstein P, Gallis B.

J Biol Chem. 1981 Jul 10;256(13):6519-22.

47.

Coordinate transcriptional regulation of type I procollagen genes by Rous sarcoma virus.

Sandmeyer S, Gallis B, Bornstein P.

J Biol Chem. 1981 May 25;256(10):5022-8.

48.

An avian oncovirus mutant deficient in genomic RNA: characterization of the packaged RNA as cellular messenger RNA.

Gallis B, Linial M, Eisenman R.

Virology. 1979 Apr 15;94(1):146-61. No abstract available.

PMID:
220781
49.

Synthesis of the precursor to avian RNA tumor virus internal structural proteins early after infection.

Gallis BM, Eisenman RN, Diggelmann H.

Virology. 1976 Oct 15;74(2):302-13. No abstract available.

PMID:
185796

Supplemental Content

Loading ...
Support Center